Memory and cellular immunity induced by a DNA vaccine encoding self antigen TPD52 administered with soluble GM-CSF

Cancer Immunology, Immunotherapy

Volumn 58, Issue 8, 2009, Pages 1337-1349

  Lewis, Jennifer D ^a   Sullivan, Laura A ^b   Byrne, Jennifer A ^c   De Riese, Werner ^a   Bright, Robert K ^a  

^a TEXAS TECH UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

DNA vaccine; GM CSF; MD52; TPD52; TRAMP C1

Indexed keywords

DNA VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PLASMID DNA; RECOMBINANT MD52 PROTEIN; TUMOR ANTIGEN; TUMOR PROTEIN; TUMOR PROTEIN D52; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CELL PROLIFERATION; CELL TRANSFORMATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA IMMUNIZATION; GENE OVEREXPRESSION; MALE; MEMORY CELL; METASTASIS; MOUSE; NONHUMAN; OVARY CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CARCINOMA; TH1 CELL;

ADENOCARCINOMA; ANIMALS; AUTOANTIGENS; CANCER VACCINES; CELL LINE, TUMOR; CYTOKINES; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; IMMUNOLOGIC MEMORY; MALE; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; VACCINATION; VACCINES, DNA;

EID: 66249086885     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-009-0659-x     Document Type: Article

References (36)

1. S Myllykangas J Himberg T Bohling B Nagy J Hollment S Knuutila 2006 DNA copy number amplification profiling of human neoplasms Oncogene 25 7324 7332
2. V Rodriguez Y Chen A Elkahloun A Dutra E Pak S Chandrasekharappa 2007 Chromosome 8 BAC array comparative genomic hybridization and expression analysis identify amplification and overexpression of TRMT12 in breast cancer Genes Chromosomes Cancer 46 694 707 (Pubitemid 46802337)
3. J Hicks A Krasnitz B Lakshmi NE Navin M Riggs E Leibu D Esposito J Alexander J Troge V Grubor S Yoon m Wigler K Ye AL Borresen-Dale B Naume E Schlicting L Norton T Hagerstrom L Skoog G Auer S Maner P Lundin A Zetterberg 2006 Novel patterns of genome rearrangement and their association with survival in breast cancer Genome Res 16 1465 1479
4. RL Balleine MS Fejzo P Sathasivam P Basset CL Clarke JA Byrne 2000 The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma Genes Chromosomes Cancer 29 48 57 (Pubitemid 30620498)
5. R Boutros S Fanayan M Shehata JA Byrne 2004 The tumor protein D52 family: many pieces, many puzzles Biochem Biophys Res Commun 325 1115 1121 (Pubitemid 39539228)
6. JA Byrne C Tomasetto JM Granier N Rouyer MG Mattei JP Bellocq MC Rio P Basset 1995 A screening method to identify genes commonly overexpressed in carcinomas and the identification of a novel complementary DNA sequence Cancer Res 55 2896 2903
7. JR Pollack T Sorlie CM Perou CA Rees SS Jeffrey PE Lonning R Tibshirani D Botstein AL Borresen-Dale PO Brown 2002 Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors Proc Natl Acad Sci USA 99 12963 12968
8. R Wang J Xu O Saramaki T Visakorpi WM Sutherland J Zhou B Sen SD Lim N Mabjeesh M Amin JT Dong JA Petros PS Nelson FF Marshall Zhau He LW Chung 2004 PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer Cancer Res 64 1589 1594 (Pubitemid 38428676)
9. R Wang J Xu N Mabjeesh G Zhu J Zhou N Amin D He FF Marshall Zhau He LW Chung 2007 PrLZ is expressed in normal prostate development and in human prostate cancer progression Clin Cancer Res 13 6040 6048 (Pubitemid 350075060)
10. MA Rubin S Varambally R Beroukhim SA Tomlins DR Rhodes PL Paris MD Hofer M Storz-Schweizer R Kuefer JA Fletcher BL Hsi JA Byrne KJ Pienta C Collins WR Sellers AM Chinnaiyan 2004 Overexpression, amplification and androgen-regulation of TPD52 in prostate cancer Cancer Res 64 3814 3822 (Pubitemid 38697290)
11. JA Byrne RL Balleine M Schoenberg Fejzo J Mercieca Y-E Chiew Y Livnat L St. Heaps G Peters K Byth BY Karlan DJ Slamon P Harnett A deFazio 2005 Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer Int J Cancer 117 1049 1054 (Pubitemid 41688583)
12. C Largo S Alvarez B Saez D Blesa JI Martin-Subero I Gonzalez-Garcia JA Brieva J Dopazo R Siebert MJ Calasanz JC Ciqudosa 2006 Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma Haematologica 91 184 191 (Pubitemid 43304137)
13. E Tiacci P-L Orvietani B Bigerna A Pucciarini A Liso R Pacini B Verducci K Pulford S Pileri M Gambacorta A Carbone R Benedetti MT Sciurpi L Binaglia JA Byrne B Falini 2005 A new monoclonal antibody (b-28p) identifies the human tumor protein D52 (TPD52) as a novel B-cell/plasma cell associated molecule with a unique expression pattern Blood 105 2812 2820 (Pubitemid 40446274)
14. SS Dave K Fu GW Wright LT Lam P Kluin EJ Boerma TC Greiner DD Weisenburger A Rosenwald G Ott HK Müller-Hermelink RD Gascoyne J Delabie LM Rimsza RM Braziel TM Grogan E Campo ES Jaffe BJ Dave W Sanger M Bast JM Vose JO Armitage JM Connors EB Smeland S Kvaloy H Holte RI Fisher TP Miller E Montserrat WH Wilson M Bahl H Zhao L Yang J Powell R Simon WC Chan LM Staudt 2006 Molecular diagnosis of Burkitt's lymphoma N Engl J Med 354 2431 2442 (Pubitemid 43855046)
15. M Hummel S Bentink H Berger W Klapper S Wessendorf TF Barth HW Bernd SB Cogliatti J Dierlamm AC Feller ML Hansmann E Haralambieva L Harder D Hasenclever M Kühn D Lenze P Lichter JI Martin-Subero P Möller HK Müller-Hermelink G Ott RM Parwaresch C Pott A Rosenwald M Rosolowski C Schwaenen B Stürzenhofecker M Szczepanowski H Trautmann HH Wacker R Spang M Loeffler L Trümper H Stein R Siebert 2006 A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling N Engl J Med 354 2419 2430 (Pubitemid 43855045)
16. P Loukopoulos T Shibata H Katoh A Kokubu M Sakamoto K Yamazaki T Kosuge Y Kanai F Hosoda I Imoto M Ohki J Inazawa S Hirohashi 2007 Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome Cancer Sci 98 392 400 (Pubitemid 46195611)
17. RI Skotheim R Autio GE Lind SM Kraggerud PW Andrews O Monni O Kallioniemi RA Lothe 2006 Novel genomic aberrations in testicular germ cell tumors by array-CGH, and associated gene expression changes Cell Oncol 28 315 326
18. JE Korkola S Heck AB Olshen VE Reuter GJ Bosl J Houldsworth RS Chaganti 2008 In vivo differentiation and genomic evolution in adult male germ cell tumors Genes Chromosomes Cancer 47 43 55 (Pubitemid 350191463)
19. A McIntyre B Summersgill YJ Lu E Missiaglia S Kitazawa JW Oosterhuis LH Looijenga J Shipley 2007 Genomic copy number and expression patterns in testicular germ cell tumours Br J Cancer 97 1707 1712 (Pubitemid 350249354)
20. KS Hoek 2007 DNA microarray analyses of melanoma gene expression: a decade in the mines Pigment Cell Res 20 466 484 (Pubitemid 47568833)
21. A Roesch B Becker S Bentink R Spang A Vogl I Hagen M Landthaler T Vogt 2007 Ataxia telangiectasia-mutated gene is a possible biomarker for discrimination of infiltrative deep penetrating nevi and metastatic vertical growth phase melanoma Cancer Epidemiol Biomarkers Prev 16 2486 2490
22. JA Byrne MG Mattei P Basset 1996 Definition of the tumor protein D52 (TPD52) gene family through cloning of D52 homologues in human (hD53) and mouse (mD52) Genomics 35 523 532 (Pubitemid 26270019)
23. JD Lewis LA Payton JG Whitford JA Byrne DI Smith L Yang RK Bright 2007 Induction of tumorigenesis and metastasis by the murine orthologue of tumor protein D52 Mol Cancer Res 5 133 144 (Pubitemid 46423994)
24. MJ Scanlan I Gout CM Gordon B Williamson E Stockert AO Gure D Jager YT Chen A Mackay MJ O'Hare LJ Old 2001 Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression Cancer Immun 1 4 20
25. LA Payton JD Lewis JA Byrne RK Bright 2008 Vaccination with metastasis-related tumor associated antigen TPD52 and CpG/ODN induces protective tumor immunity Cancer Immunol Immunother 57 799 811
26. JR Gingrich RJ Barrios RA Morton BF Boyce FJ DeMayo MJ Finegold R Angelopoulou JM Rosen NM Greenberg 1996 Metastatic prostate cancer in a transgenic mouse Cancer Res 56 4096 4102 (Pubitemid 26304996)
27. BA Foster JR Gingrich ED Kwon C Madias NM Greenberg 1997 Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model Cancer Res 57 3325 3330 (Pubitemid 27355467)
28. JD Lewis MH Shearer RC Kennedy RK Bright 2005 Surrogate tumor antigen vaccination induces tumor-specific immunity and the rejection of spontaneous metastases Cancer Res 65 2938 2946 (Pubitemid 40490099)
29. MO Li RA Flavell 2008 Contextual regulation of inflammation: a duet by transforming growth factor-β and interleukin-10 Immunity 28 468 476
30. E Gilboa 2004 The promise of cancer vaccines Nat Rev Cancer 4 401 411 (Pubitemid 38579486)
31. JD Lewis BD Reilly RK Bright 2003 Tumor associated antigens: from discovery to immunity Int Rev Immunol 22 81 112 (Pubitemid 36758540)
32. G Dranoff 2002 GM-CSF-based cancer vaccines Immunol Rev 188 147 154 (Pubitemid 35398872)
33. AD Sandler H Chihara G Kobayashi X Zhu MA Miller DL Scott AM Krieg 2003 CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma Cancer Res 63 394 399 (Pubitemid 36152498)
34. ML Disis FM Shiota DG McNeel KL Knutson 2003 Soluble cytokines can act as effective adjuvants in plasmid DNA vaccines targeting self tumor antigens Immunobiology 207 179 186 (Pubitemid 36626300)
35. LE Johnson TP Frye N Chinnasamy D Chinnasamy DG McNeel 2007 Plasmid DNA vaccine encoding prostatic acid phosphatase is effective in eliciting autologous antigen-specific CD8 + T cells Cancer Immunol Immunother 56 885 895 (Pubitemid 46723588)
36. M Pavlenko AK Roos A Lundqvist A Palmborg AM Miller V Ozenci B Bergman L Egevad M Hellström R Kiessling G Masucci P Wersäll S Nilsson P Pisa 2004 A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer Br J Cancer 91 688 694 (Pubitemid 39141625)